Glen Knight

NYC Based IT Professional

Why Your DevSecOps Initiative Will Fail

When you’ve been in and around the security industry for long enough, you get used to the industry hype machine turning a cool innovation into, uh, meh. This hype cycle starts at the RSA conference each year, and folks like me look for new hot stuff on the show floor. For perhaps only the second […]

0 Comments

Read More

Survey Shows Increased Reliance on DORA Metrics

A new survey found just under a quarter (23%) of respondents are now tracking all four of the DevOps metrics defined by the DevOps Research and Assessment Team (DORA), with another 17% now tracking three. The State of Developer Experience survey polled 129 IT professionals that play a role in software development and was conducted by […]

0 Comments

Read More

AWS Week in Review – July 4, 2022

This post is part of our Week in Review series. Check back each week for a quick roundup of interesting news and announcements from AWS! Summer has arrived in Finland, and these last few days have been hotter than in the Canary Islands! Today in the US it is Independence Day. I hope that if […]

0 Comments

Read More

DevOps Unbound EP 21 Leading a DevOps Transformation – Lessons Learned – TechStrong TV

[Music plays] Alan: Hey everyone. Welcome to another edition of Devops Unbound. Devops Unbound is a biweekly video series featuring relevant topics in devops. We go wherever we think develops is going and what we need to shine a light on. Devops Unbound is sponsored by our good friends at Tricentis and we thank […] […]

0 Comments

Read More

TechStrongCon: Time to Build an Army of Citizen Developers

DevOps teams need to start drafting a strategy to support what will soon become an army of citizen developers. Speaking at the virtual TechStrongCon event, JP Morgenthal, global director for modern applications development at DXC Technology, told conference attendees that the time to build an army of citizen developers is now. Citizen developers are typically […]

0 Comments

Read More

Clinical Trials: Programming for Scale, Speed and Success

According to the Journal of the American Medical Association (JAMA), the median cost of bringing a new drug to market is $985 million and the average cost is $1.3 billion. However, those in health care hoping to harness promising new treatments, and patients facing steep prescription costs, see this as progress. After all, previous studies […]

0 Comments

Read More